Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
For the effective treatment of bacterial infection, it is essential to find a new strategy to deliver antibacterial agents. In the present study, the co-delivery of superfine nano-silver with solubilized sulfadiazine (SD) using cyclodextrin metal-organic frameworks (CD-MOF) as a carrier exhibited superior antibacterial efficacy to insoluble silver sulfadiazine. The abundant hydroxyl moieties in CD-MOF were utilized to reduce Ag precursor into silver nanoparticles (Ag NPs) of 4-5 nm and immobilized within the nano-sized cavities. Microporous CD-MOF facilitated the inclusion of SD molecules in the hydrophobic cavities of γ-cyclodextrin (γ-CD) molecular pairs. The hydrophilic CD-MOF can easily dissolve within exudates at the wound region to release the drug. This approach improved the aqueous solubility of SD by 50 folds which subsequently enhanced SD release and their antibacterial activity. The CD framework also prevented the aggregation of nano-silver particles, stabilizing the particle size and enhancing the curative effects. Hence, the incorporation of superfine nano-silver with solubilized SD using CD-MOF could be an alternate strategy to co-deliver silver and SD with higher efficacy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijpharm.2020.119407 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!